Navigation Links
The APR Hip Family - Nonporous Fully Textured The Cost-Conscious Stem

ProductsThe APR Hip Family - Nonporous Fully Textured The Cost-Conscious Stem
Company Zimmer, Inc.
Item The APR Hip Family - Nonporous Fully Textured The Cost-Conscious Stem
Features The same geometry as the porous stem but without the porous coating. The fully textured stem offers a cost-effective, press-fit alternative to cementing.
Description The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences.
Info Zimmer, Inc.
Customer Service: (800) 613-6131
Web site: http://www.zimmer.com

Related medicine products :

1. Surgicel Absorbable Hemostat Family
2. The Natural-Hip Family - Revision/Trauma Nonporous CoCr
3. The Natural-Hip Family - Revision/Trauma CoCr Revision
4. The Natural-Hip Family - Revision/Trauma Calcar
5. The APR Hip Family - CoCr Cemented
6. The APR Hip Family - Porous (collared)
7. The APR Hip Family - Porous (collarless)
8. The APR Hip Family - Porous HA
9. The Natural-Hip Family - High Demand Porous (collarless)
10. The Natural-Hip Family - High Demand Porous (collared)
11. The Natural-Hip Family - High Demand Porous (short neck)
Rectangular Square Presentation Case
Essilor Laboratories of America
Abba optical
Distribution Center
Medicine Products:
(Date:11/9/2009)...N ARBOR, Mich., Nov. 9 The media...ear zero in the third quarter of 2008 to more than...g to an analysis of hospital financial performance...overy has been broad-based, with all classes of ho...tals, teaching hospitals and major teaching hospit...
(Date:11/9/2009)...USTON, Nov. 9 Natural Nutrition an...Inc., which will become a wholly owned subsidiary ...ll be changed to App Tech, Corp. and the company w...Global, Inc. ,, App Tech is developing mobile a...ries of the world. App Tech is focused on multi p...
(Date:11/9/2009)...N DIEGO, Nov. 9 Renewal Laboratori...pending process to produce functional beverages wi... Natural, nutritionally important supplements suc...l may now be offered in appealing and refreshing d...ue line of all natural drinks that can help mainta...
(Date:11/9/2009)... NANJING, China, Nov. 9 /PRNewswire-Asia/ -- Simc...or the "Company"), a leading pharmaceutical compan...and marketing of branded,generic and proprietary p...ent,to acquire the manufacturing license in China ... Co., Ltd. ("Tianda"). The acquisition of the,manu...
(Date:11/9/2009)...SHINGTON, Nov. 9 Today,...es brings us one step closer to meaningful health ...le Health Care for America Act makes health care m...icans by enhancing coverage, promoting preventive ...stone also serves as a sober reminder of the treme...
Breaking Medicine News(10 mins):Health News:Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study 2Health News:Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study 3Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2
...s physicians keep up to date with the latest in Ca...in the detection of cardiovascular disease. CVCTA ...ng to cardiovascular imaging. Led by Medical Direc... 2008 -- CVCTA Education of San Francisco, the l...
...atisfaction with life? Then the pen may be a might... University,s Dr. Steven Toepfer. , Toepfer, an a...at university,s Salem Campus, says that expressive...rican dream. We are wealthier than previous genera...
...TM) Campaign Reaches $1 Million Dollar Donation Go...d Banks in Need , , NEW YORK, Nov. 25 Weight...e donation of one million dollars to two hunger fi...ight Watchers Online Subscribers during Lose For G...
...rtment of Energy,s (DOE) Brookhaven National Labor...B2 for the design of a "medical synchrotron" capab...on to cancerous tumors with minimal damage to surr...lity and benefits of this treatment for cancer pat...
...o-Assisted Thoracic Surgeon Dr. Robert J. Caccaval...nce, Dedication , , SOMERSET, N.J., Nov. 25 ...ay announced that one of its leading thoracic surg...Jersey Monthly,s annual list of "Top Doctors" t...
...ional, Inc. (Amex: BUF ) today announced that it...sthetics for the human market in the United States...ned subsidiary of RxElite Inc.(OTC Bulletin Board:...n overdue accounts owed to MINRAD International, I...
Other Medicine News:Health News:CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training 2Health News:CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training 3Health News:Study: Want to be happier? Be more grateful 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 4Health News:Physicists receive patent for improved cancer therapy device 2Health News:Physicists receive patent for improved cancer therapy device 3Health News:Renowned Thoracic Surgeon Recognized as 'Top Doctor' by Peers in Annual New Jersey Monthly Magazine Survey 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 3
(Date:11/9/2009)... , BETHESDA, Md., Nov. 9 /PRNewswire-Asia...aq: CHDX ), a leading independent American provid...the People,s Republic of China, today,announced re...cal 2010, which,ended September 30, 2009. , , ... quarter of fiscal 2010 was $38.1 million, flat on...
(Date:11/9/2009)... , BEND, Oregon, November 9 /PRNewswire/ ... years of experience in applying innovative pharma...most difficult scientific and,technical problems, ...ration,with Vertex Pharmaceuticals Incorporated, a...bridge, MA. , Through this new collaborat...
(Date:11/9/2009)... , SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNew... today announced that on November 5, 2009, it rece...asdaq") stating that the Nasdaq Hearing Panel has ... The NASDAQ Global Market subject to the condition...cember 31, 2009, the proposed merger (the "Merger"...
Breaking Medicine Technology:Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Hospital Infection Prevention Resources Cut Study Says 48288 1Hospital Infection Prevention Resources Cut Study Says 48288 2Hospital Infection Prevention Resources Cut Study Says 48288 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 1Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 4AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2